APG Asset Management US Inc. Invests $455,000 in Waters Co. (NYSE:WAT)

APG Asset Management US Inc. purchased a new position in Waters Co. (NYSE:WAT - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,227 shares of the medical instruments supplier's stock, valued at approximately $455,000.

A number of other institutional investors have also recently bought and sold shares of the stock. Aster Capital Management DIFC Ltd acquired a new stake in shares of Waters during the 4th quarter valued at $28,000. Bank of Jackson Hole Trust acquired a new position in shares of Waters during the 4th quarter worth about $34,000. Fortitude Family Office LLC boosted its position in shares of Waters by 235.7% in the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after acquiring an additional 66 shares during the period. Steward Partners Investment Advisory LLC lifted its stake in shares of Waters by 129.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after buying an additional 53 shares during the period. Finally, Murphy & Mullick Capital Management Corp bought a new position in Waters during the fourth quarter valued at about $42,000. Hedge funds and other institutional investors own 94.01% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on WAT shares. UBS Group upped their price objective on Waters from $405.00 to $410.00 and gave the company a "neutral" rating in a research note on Thursday, February 13th. Bank of America dropped their price target on shares of Waters from $430.00 to $410.00 and set a "neutral" rating for the company in a research note on Thursday, February 13th. Barclays reduced their target price on Waters from $400.00 to $350.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. StockNews.com downgraded shares of Waters from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. Finally, Sanford C. Bernstein upgraded Waters from a "market perform" rating to an "outperform" rating and set a $430.00 price objective on the stock in a report on Friday, January 10th. Ten research analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $397.25.

Remove Ads

Waters Trading Down 3.3 %

WAT stock traded down $11.01 during mid-day trading on Tuesday, reaching $322.76. The company's stock had a trading volume of 146,749 shares, compared to its average volume of 474,655. Waters Co. has a 12 month low of $279.24 and a 12 month high of $423.56. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. The business's 50 day moving average price is $367.21 and its 200 day moving average price is $372.32. The company has a market cap of $19.18 billion, a price-to-earnings ratio of 30.14, a price-to-earnings-growth ratio of 3.79 and a beta of 1.04.

Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. On average, equities research analysts predict that Waters Co. will post 12.86 EPS for the current year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.